J. Roba

590 total citations
44 papers, 442 citations indexed

About

J. Roba is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, J. Roba has authored 44 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Organic Chemistry and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in J. Roba's work include Neuroscience and Neuropharmacology Research (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Synthesis and biological activity (4 papers). J. Roba is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Synthesis and biological activity (4 papers). J. Roba collaborates with scholars based in Belgium, Canada and United States. J. Roba's co-authors include G. Lambelin, Philippe Collart, Brigitte Gerin, William Trager, Gary Mather, René H. Levy, A. Cordi, Pierre Chatelain, Martine Claeys and Rhys Whomsley and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

J. Roba

42 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Roba Belgium 12 125 101 94 92 69 44 442
W. McNally United States 12 104 0.8× 54 0.5× 65 0.7× 38 0.4× 49 0.7× 16 438
Chiyuki Yamato Japan 14 157 1.3× 95 0.9× 26 0.3× 17 0.2× 58 0.8× 34 522
Tillement Jp France 11 118 0.9× 37 0.4× 41 0.4× 26 0.3× 66 1.0× 72 381
B Catanese Italy 14 139 1.1× 48 0.5× 32 0.3× 32 0.3× 105 1.5× 50 474
Dirk Thomas Germany 11 70 0.6× 64 0.6× 136 1.4× 135 1.5× 58 0.8× 22 495
Michael Shalmi Denmark 13 224 1.8× 31 0.3× 39 0.4× 40 0.4× 49 0.7× 39 530
Shizuo Yamada Japan 10 112 0.9× 83 0.8× 55 0.6× 29 0.3× 19 0.3× 11 308
André Esanu France 11 220 1.8× 81 0.8× 26 0.3× 20 0.2× 47 0.7× 25 614
Ali R. Saadatmand Germany 10 103 0.8× 42 0.4× 184 2.0× 48 0.5× 61 0.9× 12 501
J. Prous Spain 12 246 2.0× 50 0.5× 17 0.2× 68 0.7× 96 1.4× 27 665

Countries citing papers authored by J. Roba

Since Specialization
Citations

This map shows the geographic impact of J. Roba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Roba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Roba more than expected).

Fields of papers citing papers by J. Roba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Roba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Roba. The network helps show where J. Roba may publish in the future.

Co-authorship network of co-authors of J. Roba

This figure shows the co-authorship network connecting the top 25 collaborators of J. Roba. A scholar is included among the top collaborators of J. Roba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Roba. J. Roba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nicolas, Jean‐Marie, Rhys Whomsley, Philippe Collart, & J. Roba. (1999). In vitro inhibition of human liver drug metabolizing enzymes by second generation antihistamines. Chemico-Biological Interactions. 123(1). 63–79. 30 indexed citations
2.
Collart, Philippe, Brigitte Gerin, Gary Mather, et al.. (1999). In Vitro Evaluation of Potential Drug Interactions With Levetiracetam, A New Antiepileptic Agent. Drug Metabolism and Disposition. 27(2). 250–254. 93 indexed citations
3.
Rogiers, Vera, et al.. (1997). Observation of hepatotoxic effects of 2-n-pentylaminoacetamide (Milacemide) in rat liver by a combined in vivo/ in vitro approach. Archives of Toxicology. 71(5). 271–282. 4 indexed citations
4.
Roba, J., et al.. (1995). Effect of Folate Supplementation on Clinical Chemistry and Hematologic Changes Related to Bidisomide Administration in the Rat. Drug and Chemical Toxicology. 18(4). 235–270. 3 indexed citations
5.
Vandenberghe, Yves, et al.. (1994). Deoxyuridine suppression test on isolated rat bone marrow cells and the in vitro effect of bidisomide. Toxicology in Vitro. 8(2). 277–282. 2 indexed citations
6.
Hérin, Michel, et al.. (1994). Comparative metabolism of SC-42867 and SC-51089, two PGE2antagonists, in rat and human hepatocyte cultures. Xenobiotica. 24(1). 25–36. 12 indexed citations
7.
Bovy, Philippe R., et al.. (1988). Synthesis and aldose reductase inhibition activity of spiro-[9H-fluoren-9,4′-imidazolidine]-2′,5′-dione derivatives. European Journal of Medicinal Chemistry. 23(2). 165–172. 4 indexed citations
8.
Chatelain, Pierre, et al.. (1984). Comparison of [nitrendipine-h-3 Binding To Heart Membranes of Normotensive and Spontaneously Hypertensive Rats. Digital Access to Libraries. 22 indexed citations
9.
Stul, Michel, A. Lenaers, J.M. Foidart, P. Niebes, & J. Roba. (1983). Comparison of Aortic Smooth-muscle Cells From Normotensive and Spontaneously Hypertensive Rats in Culture. Archives of Physiology and Biochemistry. 91(2). 1 indexed citations
10.
Roba, J., G. Defreyn, & G. Biagi. (1983). Antithrombotic activity of suloctidil. Thrombosis Research. 29. 53–58. 5 indexed citations
11.
Pasteéls, Jacques M., et al.. (1979). Cardiac glycosides in the defensive secretion of Chrysolina herbacea (Coleoptera, Chrysomelidae). Identification, biological role and pharmacological activity. Comparative Biochemistry and Physiology Part C Comparative Pharmacology. 63(1). 117–121. 1 indexed citations
12.
Roba, J., et al.. (1977). Clinical and metabolic aspects of adjuvant arthritis.. PubMed. 31(3). 143–52. 6 indexed citations
13.
Peeters, Hilde, V. Blaton, Dries Vandamme, et al.. (1977). Effects of suloctidil on lipid metabolism in experimental animals.. PubMed. 27(10). 1964–7.
14.
Roba, J., R. Roncucci, & G. Lambelin. (1977). Pharmacological Properties of Suloctidil. Acta Clinica Belgica. 32(1). 3–7. 11 indexed citations
15.
Lambelin, G., et al.. (1975). Carcinogenicity of 6-aminochrysene in mice. European Journal of Cancer (1965). 11(5). 327–334. 11 indexed citations
16.
Lambelin, G. & J. Roba. (1974). Curative activity of a sulphated polygalactoside (CP 1200) ON EXPERIMENTAL GASTRIC ULCERS IN THE RAT.. PubMed. 211(1). 18–23. 1 indexed citations
17.
Roba, J., G. Lambelin, & De Schaepdryver Af. (1972). Antihypertensive activity of four blocking agents in spontaneously hypertensive rats.. PubMed. 200(1). 182–90. 18 indexed citations
18.
Lambelin, G., et al.. (1971). Cutaneous thermometry for topical therapy evalaation of U. V. erythema in the guinea-pig.. PubMed. 21(1). 44–7. 4 indexed citations
19.
Lambelin, G., et al.. (1970). Pharmacology of a new analgesic, antipyretic, and anti-inflammatory agent, 4-allyloxy-3-chlorophenylacetic acid.. PubMed. 20(5). 610–8. 20 indexed citations
20.
Lambelin, G., et al.. (1968). Relationships between structure and four types of pharmacologic activity in arylacetydroxamic acids.. PubMed. 18(11). 1404–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026